Harvard Bioscience Inc (HBIO)
2.29
+0.12
(+5.53%)
USD |
NASDAQ |
Nov 14, 16:00
2.295
0.00 (0.00%)
Pre-Market: 20:00
Harvard Bioscience Cash from Operations (Quarterly): -0.842M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.842M |
| June 30, 2024 | -0.846M |
| March 31, 2024 | 1.403M |
| December 31, 2023 | 4.303M |
| September 30, 2023 | 4.361M |
| June 30, 2023 | 3.552M |
| March 31, 2023 | 1.812M |
| December 31, 2022 | 2.679M |
| September 30, 2022 | 0.649M |
| June 30, 2022 | -0.19M |
| March 31, 2022 | -1.986M |
| December 31, 2021 | 0.117M |
| September 30, 2021 | -0.66M |
| June 30, 2021 | 0.768M |
| March 31, 2021 | 1.037M |
| December 31, 2020 | 2.49M |
| September 30, 2020 | 1.597M |
| June 30, 2020 | 2.373M |
| March 31, 2020 | 2.871M |
| December 31, 2019 | 2.22M |
| September 30, 2019 | 3.158M |
| June 30, 2019 | 0.657M |
| March 31, 2019 | 2.01M |
| December 31, 2018 | 2.593M |
| September 30, 2018 | -1.434M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.277M |
| March 31, 2018 | 0.448M |
| December 31, 2017 | -0.939M |
| September 30, 2017 | 2.131M |
| June 30, 2017 | 0.475M |
| March 31, 2017 | -0.61M |
| December 31, 2016 | 1.727M |
| September 30, 2016 | 3.44M |
| June 30, 2016 | 0.942M |
| March 31, 2016 | -0.726M |
| December 31, 2015 | 1.764M |
| September 30, 2015 | -0.078M |
| June 30, 2015 | -0.484M |
| March 31, 2015 | -0.497M |
| December 31, 2014 | 1.263M |
| September 30, 2014 | 0.602M |
| June 30, 2014 | 1.414M |
| March 31, 2014 | 1.072M |
| December 31, 2013 | 1.249M |
| September 30, 2013 | 1.431M |
| June 30, 2013 | 0.804M |
| March 31, 2013 | 0.576M |
| December 31, 2012 | 1.406M |
| September 30, 2012 | 2.503M |
| June 30, 2012 | 2.548M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.986M
Minimum
Mar 2022
4.361M
Maximum
Sep 2023
1.385M
Average
1.50M
Median
Cash from Operations (Quarterly) Benchmarks
| Bruker Corp | 38.40M |
| Azenta Inc | 1.791M |
| Bionano Genomics Inc | -20.98M |
| Akoya Biosciences Inc | -11.04M |
| Singular Genomics Systems Inc | -18.04M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.111M |
| Cash from Financing (Quarterly) | 2.104M |
| Free Cash Flow | 0.16M |
| Free Cash Flow Per Share (Quarterly) | -0.0448 |
| Free Cash Flow to Equity (Quarterly) | -4.131M |
| Free Cash Flow to Firm (Quarterly) | -1.038M |
| Free Cash Flow Yield | 0.16% |